![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 9, 6055-6058, March 3, 2000
§¶ and
From the
Molecular Biology and Virology Laboratory,
The Salk Institute for Biological Studies, La Jolla, California
92037 and the § Department of Biology, University of
California, San Diego, La Jolla, California 92093
| |
ABSTRACT |
|---|
|
|
|---|
Exposure of cells to oxidants increases the
phosphorylation of the Src family tyrosine protein kinase Lck at
Tyr-394, a conserved residue in the activation loop of the catalytic
domain. Kinase-deficient Lck expressed in fibroblasts that do not
express any endogenous Lck has been shown to be phosphorylated at
Tyr-394 following H2O2 treatment to an
extent indistinguishable from that seen with wild type Lck. This
finding indicates that a kinase other than Lck itself is capable of
phosphorylating Tyr-394. Because fibroblasts express other Src family
members, it remained to be determined whether the phosphorylation of
Tyr-394 was carried out by another Src family kinase or by an unrelated
tyrosine protein kinase. We examined here whether Tyr-394 in
kinase-deficient Lck was phosphorylated following exposure of cells
devoid of endogenous Src family kinase activity to
H2O2. Strikingly, treatment of such cells with
H2O2 led to the phosphorylation of Tyr-394 to
an extent identical to that seen with wild type Lck, demonstrating that
Src family kinases are not required for
H2O2-induced phosphorylation of Lck.
Furthermore, this efficient phosphorylation of Lck at Tyr-394 in
non-lymphoid cells suggests the existence of an ubiquitous activator of
Src family kinases.
Members of the Src family of non-receptor tyrosine protein kinases
have important roles in controlling growth, proliferation, and
differentiation (1). For example, the Src family kinases c-Src, Yes,
and Fyn are required for integrin-mediated signaling in response to
cell adhesion to the extracellular matrix (2). Additionally, Lck, a
lymphoid cell-specific member of the Src family (3), is essential for
both the development of T cells in the thymus and the response of
mature T cells to signals arising from the T-cell antigen receptor (4,
5).
Src family kinases are 52-62-kDa cytoplasmic proteins consisting of an
acylated N-terminal unique domain that mediates association with the
plasma membrane, an SH31
domain, an SH2 domain, a catalytic domain, and a short C-terminal regulatory tail (6). The SH3 domain interacts with poly-proline type II
helices (7), whereas the SH2 domain binds sites of tyrosine
phosphorylation (8). Both the SH3 and SH2 domains play a role in the
intramolecular regulation of Src family kinase activity (9, 10).
The kinase activity of Src family members can be both inhibited and
activated by phosphorylation. Phosphorylation of a conserved tyrosine
near the C terminus (Tyr-505 in Lck, Tyr-527 in c-Src) by the
ubiquitous tyrosine protein kinase Csk (11, 12) induces formation of a
biologically inactive conformation by allowing intramolecular binding
of the SH2 domain to the phosphorylated C terminus (9, 13, 14). This
inactive "closed" conformation is further stabilized by binding of
the SH3 domain to the linker between the SH2 domain and the catalytic
domain (9, 10). Dephosphorylation of this site by the tyrosine
phosphatase CD45, in the case of Lck, or R-PTP- In contrast, phosphorylation of a conserved tyrosine in the activation
loop (Tyr-394 in Lck, Tyr-416 in c-Src) enhances kinase activity
(19-21). In Lck, the phosphorylation of Tyr-394 is activating because
it stabilizes the catalytic active site by forming hydrogen bonds with
Arg-387 and Arg-363 and hydrophobic interactions with Ile-361 and
Ile-389 (22). Phosphorylation of this site can be carried out by the
kinase itself, and it is the major site of "autophosphorylation"
in vitro (23, 24). Studies of c-Src activity in
vitro and in yeast indicate that phosphorylation of the activation
loop in c-Src is an intermolecular autophosphorylation event (25, 26).
The same appears to be the case with Lck and Lyn (21, 27).
Dephosphorylation of Tyr-394 in Lck is mediated by the tyrosine
phosphatases PEP and SHP-1
(28).2
Exposure of cells to oxidants such as hydrogen peroxide and pervanadate
induces the rapid tyrosine phosphorylation of multiple cellular
proteins (29) and mimics stimulation by growth factors such as
epidermal growth factor or platelet-derived growth factor (30, 31) or
antigen receptor cross-linking (32). These agents have this effect
because both inhibit the activity of protein tyrosine phosphatases
through the oxidation of an essential catalytic cysteine (33-36). The
induced phosphorylation on tyrosine results, at least in part, from
cessation of dephosphorylation in the oxidant-treated cells.
Hydrogen peroxide stimulates the activity of Src family kinases.
Endogenously produced H2O2 stimulates the
activity of the Src family kinases c-Fgr and Lyn in adherent
neutrophils (37). Exposure of Jurkat T cells or Lck-expressing rat 208F
fibroblasts to H2O2 induces the phosphorylation
of Tyr-394 and enhances Lck kinase activity (21). Interestingly, this
oxidant-induced phosphorylation of Tyr-394 in Lck occurs at an
undiminished rate in fibroblasts expressing only kinase-deficient forms
of Lck. Therefore, the kinase activity of Lck is not required for the
oxidant-induced phosphorylation of Tyr-394, and another tyrosine
protein kinase may function as an activator of Lck (21). The kinase
that phosphorylates Tyr-394 in H2O2-treated
fibroblasts could be either another Src kinase or an as yet
unidentified kinase. To distinguish between these possibilities, we
took advantage of the cell line SYF, which is derived from mutant mouse
embryos lacking the Src family members c-Src, Yes, and Fyn (2).
Additionally, the SYF cell line does not express Lyn (2). We expressed
kinase-deficient Lck in SYF cells and analyzed the phosphorylation of
Tyr-394 following cellular exposure to
H2O2.
Cell Culture--
293, a human embryonic kidney cell line, was
grown in DMEM (Cellgro, Mediatech) supplemented with 10% calf serum
(Hyclone). Jurkat, a human leukemic T-cell line was maintained in RPMI
1640 medium supplemented with 10% fetal calf serum (Intergen) and 2 mM glutamine. SYF (2), a murine embryonic fibroblast cell
line derived from mutant embryos deficient for c-Src, Yes, and Fyn (a
kind gift from Drs. R. Klinghoffer and P. Soriano, Fred Hutchinson Cancer Research Center, Seattle, WA), was maintained in DMEM
supplemented with 10% fetal calf serum.
DNA Constructs and Retroviral Infections--
Wild type Lck (WT)
and kinase-deficient Lck (R273) cDNAs have been previously
described (21, 38). The lck cDNAs were subcloned into
the retroviral vector MSCVhph (39) from the retroviral vector LXSN (40)
to utilize hygromycin B phosphotransferase as a selectable marker.
Recombinant retroviruses were produced by cotransfecting the MSCV-Lck
constructs along with the viral helper plasmid
SV- Cell Lysis and Immunoprecipitations--
Cells were washed once
with Tris-buffered saline and lysed in either RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1%
SDS, 100 kallikrein-inactivating units/ml aprotinin) or Tris/Nonidet
P-40 lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 100 kallikrein-inactivating units/ml aprotinin) for 20 min at 4 °C.
Lysates were clarified by centrifugation at 35,000 × g
for 30 min. Lysates were subjected to immunoprecipitation using a
rabbit anti-Lck antibody as described previously (42). Immune complexes
were collected on Pansorbin cells (Calbiochem), washed three times in
either RIPA or Tris/Nonidet P-40 buffer, and used for subsequent analysis.
In Vitro Kinase Assay--
SYF cells or Jurkat T cells were
lysed in Tris/Nonidet P-40 lysis buffer as described. Anti-Lck
immunoprecipitates were resuspended in kinase buffer (40 mM
PIPES, pH 7.2, 10 mM MnCl2). Kinase reactions were initiated by adding 5 µCi of [ Immunoblotting--
Immunoprecipitated Lck was resolved by
SDS-PAGE and transferred to an Immobilon-P membrane (Millipore).
Western blotting was carried out with rabbit anti-Lck antibodies as
described previously (42) and enhanced chemiluminescence.
In Vivo Labeling and Two-dimensional Tryptic Peptide
Mapping--
SYF cells were plated at a density of 1.5 × 106 cells/5-cm plate, 16 h prior to labeling.
Immediately prior to labeling, cells were washed twice in
phosphate-free DMEM. Cells were biosynthetically labeled in 2 ml of
phosphate-free DMEM supplemented with 10% dialyzed fetal calf serum
containing 32Pi
(H332PO4, ICN, 0.5 mCi/ml) for
2 h at 37 °C. For H2O2 treatment,
H2O2 was added to a final concentration of 5 mM, and cells were incubated for 15 min at 37 °C. Cells
were washed with Tris-buffered saline and lysed in RIPA buffer, and
32P-labeled Lck was isolated by immunoprecipitation as
described. 32P-labeled Lck was resolved by SDS-PAGE,
transferred to a nitrocellulose membrane, and excised from the membrane
following identification by autoradiography. The excised membrane
containing the labeled Lck was then digested with TPCK-trypsin as
described previously (43). Two-dimensional tryptic peptide mapping was
carried out on cellulose thin layer chromatography plates (EM Science)
by electrophoresis at pH 8.9 in the first dimension followed by
ascending chromatography in phosphochromatography buffer in the second
dimension as described previously (44). The labeled peptides were
visualized with a PhosphorImager (Molecular Dynamics).
Stable Expression of WT Lck and R273 Lck in SYF Cells--
To
express wild type Lck and the kinase-deficient R273 Lck in SYF cells,
we infected the cells with recombinant MSCVhph retroviruses. Following
antibiotic selection, pools of selected cells were tested for both Lck
expression and kinase activity. Anti-Lck immunoprecipitates were
analyzed by Western blotting using anti-Lck antibodies or were
subjected to an in vitro kinase reaction. Uninfected SYF cells did not express Lck (Fig.
1A, lane 1). SYF
cells infected with WT- or R273 Lck-encoding virus expressed readily
detectable levels of Lck (Fig. 1A, lanes 2 and
3). Wild type Lck from the SYF cells exhibited robust kinase
activity (Fig. 1B, lane 2). In contrast, the R273
Lck did not exhibit any detectable kinase activity (Fig. 1B,
lane 3). Because we were able to detect phosphorylated bands
with 0.5% of the intensity of the wild type Lck signal, we estimate
that the activity of the R273 Lck is at least 200-fold lower than that
of the wild type kinase. H2O2 treatment of SYF cells expressing R273 Lck had no detectable effect on the activity of
the mutant kinase (data not shown).
Kinase-deficient Lck Is Phosphorylated at Tyrosine 394 in SYF Cells
following H2O2 Treatment--
It has been
shown previously that exposure of both Jurkat T cells and 208F
fibroblasts expressing wild type Lck to H2O2
induces the phosphorylation of Lck at Tyr-394 (21). To determine
whether this is also the case in SYF cells, we biosynthetically labeled cells expressing wild type Lck with 32Pi and
immunoprecipitated Lck both before and after exposure to 5 mM H2O2. The phosphorylation of the protein
was examined by two-dimensional tryptic peptide analysis (Fig.
2). Wild type Lck was predominately
phosphorylated on Tyr-505 in untreated cells (Fig. 2A). A
trace of phosphorylation at Tyr-394 (2% of the level of Tyr-505) was
also observed in untreated cells. Following exposure of the labeled
cells to H2O2, wild type Lck became
phosphorylated at Tyr-394 to an extent equal to that of Tyr-505 (Fig.
2B). The identity of the tryptic peptide containing Tyr-394
was confirmed by its co-migration with the predominant phosphorylated
peptide from Lck labeled in vitro by incubation with
[
To determine whether kinase-deficient Lck could be phosphorylated at
Tyr-394 in cells lacking all Src family kinases, we treated SYF cells
expressing R273 Lck with H2O2 and analyzed Lck
phosphorylation as detailed above. R273 Lck was phosphorylated at
Tyr-505 with no detectable Tyr-394 phosphorylation in untreated SYF
cells (Fig. 2C). Strikingly, H2O2
treatment of SYF cells expressing kinase-deficient Lck led to the
phosphorylation of Tyr-394 to an extent equal to that of Tyr-505 (Fig.
2D). Pervanadate treatment of SYF cells expressing R273 Lck
gave identical results to that seen with H2O2, indicating that this phenomenon is not specific to
H2O2 (data not shown). It is clear that the
lack of Lck kinase activity has no effect on
H2O2-induced phosphorylation of tyrosine 394, even in cells completely lacking Src family kinases.
Many serine/threonine protein kinases are activated by
phosphorylation in the activation loop. This activating phosphorylation is usually carried out by a specific upstream activator. For example, the cyclin-dependent kinases (Cdks) are stimulated by the
Cdk-activating kinase, CAK, in this manner (45). Additionally, protein
kinase B/c-Akt, cAMP-dependent protein kinase, p70 S6
kinase, and several protein kinase C isoforms are all activated by the
3-phosphoinositide-dependent kinase, PDK1 (46-50).
Furthermore, mitogen-activated protein (MAP) kinases are activated by
phosphorylation by MAP kinase kinases, such as MEK1 (51-54).
Src family kinases are also activated by phosphorylation of a conserved
tyrosine in the activation loop. This phosphorylation traditionally has
been thought to occur as an intermolecular event carried out by the
kinase itself (25, 26). Our data, however, suggest that phosphorylation
of the activation loop tyrosine need not be performed by Src family
kinases. Using SYF cells, which are devoid of all known Src family
kinase activity, we have demonstrated that H2O2
and pervanadate induce phosphorylation of kinase-deficient Lck at
Tyr-394 to an extent equal to that of wild type Lck. Therefore, our
results argue strongly that the oxidant-induced phosphorylation of Lck
at Tyr-394 is not catalyzed exclusively by Src family members and may
be carried out by another tyrosine protein kinase(s) that is
functionally analogous to activators of serine/threonine protein kinases.
In the absence of a completely sequenced mammalian genome, the formal
possibility that the tyrosine protein kinase responsible for the
phosphorylation of Lck at Tyr-394 is a Src family kinase that has
escaped detection to date cannot be excluded. However, the defective
integrin-mediated signaling phenotype of the SYF cells (2) argues
against the expression of a heretofore unidentified Src family member
that can functionally complement for the c-Src, Yes, and Fyn deficiency
in these cells. Therefore, the simplest interpretation of our results
is that a non-Src family kinase is responsible for the oxidant-induced
phosphorylation of Lck. We have not yet determined whether the
kinase(s) responsible for phosphorylation of Lck at Tyr-394 is itself
stimulated by hydrogen peroxide or whether its activity is constitutive
and the increased phosphorylation of Tyr-394 is due simply to
inhibition of a tyrosine phosphatase. Because Lck is normally expressed
only in lymphoid cells, the fact that kinase-deficient Lck is
phosphorylated in non-lymphoid cells following exposure to oxidants
suggests that a general activator of Src family kinases may exist.
Characterization of this kinase(s) in SYF cells may provide insight
into this alternative mechanism of Src family kinase activation. We
suspect that phosphorylation of the activation loop tyrosine in Src
kinases will be shown to be carried out by Src family kinases in some
circumstances and by one or more non-Src kinases in others.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, in the case of
c-Src, activates the kinase (15-18).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

E-MLV (41) into 293 cells using a calcium phosphate
transfection system (Life Technologies, Inc.). 48 h
post-transfection, supernatant containing recombinant virus particles
was collected, filtered through an 0.45-µm filter to remove cells and
debris, and used to infect SYF cells. 48 h post-infection, cells
expressing WT Lck or R273 Lck were selected with 400 µg/ml hygromycin
B (Calbiochem) in DMEM supplemented with 10% fetal calf serum.
-32P]ATP (3000 ci/mmol, ICN) and incubated at 30 °C for 20 min.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (43K):
[in a new window]
Fig. 1.
Analysis of Lck expression and kinase
activity in infected SYF cells. Lck was immunoprecipitated from
SYF cells expressing WT Lck or R273 Lck and divided into equal
fractions. A, Lck immunoprecipitates were resolved by
SDS-PAGE, transferred to Immobilon-P, and analyzed by Western blotting
using anti-Lck antibodies and enhanced chemiluminescence. B,
Lck immunoprecipitates (IP) were subjected to an in
vitro kinase assay followed by SDS-PAGE. 32P-labeled
Lck was visualized using a PhosphorImager. Lane 1, anti-Lck
immunoprecipitates from uninfected SYF cells; lane 2,
anti-Lck immunoprecipitates from SYF cells infected with wild type Lck;
lane 3, anti-Lck immunoprecipitates from SYF cells infected
with kinase-deficient Lck.
-32P]ATP, when mixtures of peptides from two samples
were examined by two-dimensional tryptic peptide analysis (Fig. 2,
E and F, and data not shown). The trace
phosphorylation at Tyr-394 in wild type Lck observed in untreated cells
is presumably due to Lck autophosphorylation because kinase-deficient
Lck was not phosphorylated at Tyr-394 in untreated cells (Fig. 2,
compare A with C)

View larger version (64K):
[in a new window]
Fig. 2.
Analysis of Lck phosphorylation in SYF cells
following stimulation with H2O2. Lck was
immunoprecipitated from 32P-labeled cells before or after
treatment with 5 mM H2O2 for 15 min
and analyzed by two-dimensional tryptic peptide mapping on thin layer
cellulose plates. A, WT Lck from untreated SYF cells;
B, WT Lck from H2O2-treated SYF
cells; C, R273 Lck from untreated SYF cells; D,
R273 Lck from treated SYF cells; E, WT Lck isolated from
Jurkat T cells, labeled in an in vitro kinase assay;
F, mixture of peptides analyzed in D and
E. Origins are marked with arrowheads.
Arrows indicate directions of electrophoresis and
chromatography. Y505, peptide containing phosphorylated
Tyr-505. Y394, peptide containing phosphorylated
Tyr-394.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We are indebted to Richard Klinghoffer and Philippe Soriano for the very generous gift of the SYF cells, and we thank Kambiz Amdjadi and Roberta Schulte for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by Grants CA14195 and CA42350 from NCI, National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Supported by Training Grant T32-CA09435 from NCI, National Institutes of Health and a fellowship from the Chapman Charitable Trust. To whom correspondence should be addressed: Molecular Biology and Virology Lab., The Salk Institute, 10010 N. Torrey Pines Rd., La Jolla, CA 92037. Tel: 858-453-4100, ext. 1331; Fax: 858-457-4765; E-mail: gchiang@ucsd.edu.
2 G. G. Chiang and B. M. Sefton, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: SH2, Src homology 2; SH3, Src homology 3; WT, wild type; R273 Lck, kinase-deficient Lck; DMEM, Dulbecco-Vogt's modified Eagle's medium; PIPES, 1,4-piperazinediethanesulfonic acid; PAGE, polyacrylamide gel electrophoresis; TPCK, L-1-tosylamido-2-phenylethyl chloromethyl ketone.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Thomas, S. M., and Brugge, J. S. (1997) Annu. Rev. Cell Dev. Biol. 13, 513-609[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., and Soriano, P. (1999) EMBO J. 18, 2459-2471[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Sefton, B. M., and Campbell, M. A. (1991) Annu. Rev. Cell Biol. 7, 257-274[CrossRef] |
| 4. | Molina, T. J., Kishihara, K., Siderovski, D. P., van Ewijk, W., Narendran, A., Timms, E., Wakeham, A., Paige, C. J., Hartmann, K. U., Veillette, A., Davidson, D., and Mak, T. W. (1992) Nature 357, 161-164[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Straus, D. B., and Weiss, A. (1992) Cell 70, 585-593[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Brown, M. T., and Cooper, J. A. (1996) Biochim. Biophys. Acta 1287, 121-149[Medline] [Order article via Infotrieve] |
| 7. | Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., and Schreiber, S. L. (1994) Cell 76, 933-945[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Eck, M. J., Shoelson, S. E., and Harrison, S. C. (1993) Nature 362, 87-91[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Sicheri, F., Moarefi, I., and Kuriyan, J. (1997) Nature 385, 602-609[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Xu, W., Harrison, S. C., and Eck, M. J. (1997) Nature 385, 595-602[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Thomas, J. E.,
Soriano, P.,
and Brugge, J. S.
(1991)
Science
254,
568-571 |
| 12. | Nada, S., Okada, M., MacAuley, A., Cooper, J. A., and Nakagawa, H. (1991) Nature 351, 69-72[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Bergman, M., Mustelin, T., Oetken, C., Partanen, J., Flint, N. A., Amrein, K. E., Autero, M., Burn, P., and Alitalo, K. (1992) EMBO J. 11, 2919-2924[Medline] [Order article via Infotrieve] |
| 14. | Sieh, M., Bolen, J. B., and Weiss, A. (1993) EMBO J. 12, 315-321[Medline] [Order article via Infotrieve] |
| 15. |
Ostergaard, H. L.,
Shackelford, D. A.,
Hurley, T. R.,
Johnson, P.,
Hyman, R.,
Sefton, B. M.,
and Trowbridge, I. S.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
8959-8963 |
| 16. |
Ostergaard, H. L.,
and Trowbridge, I. S.
(1990)
J. Exp. Med.
172,
347-350 |
| 17. |
Mustelin, T.,
Coggeshall, K. M.,
and Altman, A.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
6302-6306 |
| 18. | Su, J., Muranjan, M., and Sap, J. (1999) Curr. Biol. 9, 505-511[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Boulet, I., Fagard, R., and Fischer, S. (1987) Biochem. Biophys. Res. Commun. 149, 56-64[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Abraham, N.,
and Veillette, A.
(1990)
Mol. Cell. Biol.
10,
5197-5206 |
| 21. |
Hardwick, J. S.,
and Sefton, B. M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4527-4531 |
| 22. | Yamaguchi, H., and Hendrickson, W. A. (1996) Nature 384, 484-489[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Casnellie, J. E.,
Harrison, M. L.,
Hellstrom, K. E.,
and Krebs, E. G.
(1982)
J. Biol. Chem.
257,
13877-13879 |
| 24. |
Voronova, A. F.,
Buss, J. E.,
Patschinsky, T.,
Hunter, T.,
and Sefton, B. M.
(1984)
Mol. Cell. Biol.
4,
2705-2713 |
| 25. | Barker, S. C., Kassel, D. B., Weigl, D., Huang, X., Luther, M. A., and Knight, W. B. (1995) Biochemistry 34, 14843-14851[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Cooper, J. A.,
and MacAuley, A.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4232-4236 |
| 27. |
Sotirellis, N.,
Johnson, T. M.,
Hibbs, M. L.,
Stanley, I. J.,
Stanley, E.,
Dunn, A. R.,
and Cheng, H. C.
(1995)
J. Biol. Chem.
270,
29773-29780 |
| 28. |
Cloutier, J. F.,
and Veillette, A.
(1999)
J. Exp. Med.
189,
111-121 |
| 29. | Suzuki, Y. J., Forman, H. J., and Sevanian, A. (1997) Free Radical Biol. Med. 22, 269-285[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Rao, G. N. (1996) Oncogene 13, 713-719[Medline] [Order article via Infotrieve] |
| 31. |
Sundaresan, M., Yu, Z. X.,
Ferrans, V. J.,
Irani, K.,
and Finkel, T.
(1995)
Science
270,
296-299 |
| 32. |
Secrist, J. P.,
Burns, L. A.,
Karnitz, L.,
Koretzky, G. A.,
and Abraham, R. T.
(1993)
J. Biol. Chem.
268,
5886-5893 |
| 33. | Hecht, D., and Zick, Y. (1992) Biochem. Biophys. Res. Commun. 188, 773-779[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Sullivan, S. G., Chiu, D. T., Errasfa, M., Wang, J. M., Qi, J. S., and Stern, A. (1994) Free Radical Biol. Med. 16, 399-403[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Denu, J. M., and Tanner, K. G. (1998) Biochemistry 37, 5633-5642[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Huyer, G.,
Liu, S.,
Kelly, J.,
Moffat, J.,
Payette, P.,
Kennedy, B.,
Tsaprailis, G.,
Gresser, M. J.,
and Ramachandran, C.
(1997)
J. Biol. Chem.
272,
843-851 |
| 37. |
Yan, S. R.,
and Berton, G.
(1996)
J. Biol. Chem.
271,
23464-23471 |
| 38. | Voronova, A. F., and Sefton, B. M. (1986) Nature 319, 682-685[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Hawley, R. G., Lieu, F. H., Fong, A. Z., and Hawley, T. S. (1994) Gene Ther. 1, 136-138[Medline] [Order article via Infotrieve] |
| 40. | Miller, A. D., and Rosman, G. J. (1989) BioTechniques 7, 980-990[Medline] [Order article via Infotrieve] |
| 41. |
Muller, A. J.,
Young, J. C.,
Pendergast, A. M.,
Pondel, M.,
Landau, N. R.,
Littman, D. R.,
and Witte, O. N.
(1991)
Mol. Cell. Biol.
11,
1785-1792 |
| 42. | Hurley, T. R., and Sefton, B. M. (1989) Oncogene 4, 265-272[Medline] [Order article via Infotrieve] |
| 43. | Luo, K., Hurley, T. R., and Sefton, B. M. (1990) Oncogene 5, 921-923[Medline] [Order article via Infotrieve] |
| 44. |
Hunter, T.,
and Sefton, B. M.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
1311-1315 |
| 45. | Kaldis, P. (1999) Cell. Mol. Life Sci. 55, 284-296[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B., and Cohen, P. (1997) Curr. Biol. 7, 261-269[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Cheng, X.,
Ma, Y.,
Moore, M.,
Hemmings, B. A.,
and Taylor, S. S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9849-9854 |
| 48. | Alessi, D. R., Kozlowski, M. T., Weng, Q. P., Morrice, N., and Avruch, J. (1998) Curr. Biol. 8, 69-81[CrossRef][Medline] [Order article via Infotrieve] |
| 49. |
Le Good, J. A.,
Ziegler, W. H.,
Parekh, D. B.,
Alessi, D. R.,
Cohen, P.,
and Parker, P. J.
(1998)
Science
281,
2042-2045 |
| 50. | Dutil, E. M., Toker, A., and Newton, A. C. (1998) Curr. Biol. 8, 1366-1375[CrossRef][Medline] [Order article via Infotrieve] |
| 51. |
Cobb, M. H.,
and Goldsmith, E. J.
(1995)
J. Biol. Chem.
270,
14843-14846 |
| 52. | Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H., and Goldsmith, E. J. (1997) Cell 90, 859-869[CrossRef][Medline] [Order article via Infotrieve] |
| 53. | Su, B., and Karin, M. (1996) Curr. Opin. Immunol. 8, 402-411[CrossRef][Medline] [Order article via Infotrieve] |
| 54. | Garrington, T. P., and Johnson, G. L. (1999) Curr. Opin. Cell Biol. 11, 211-218[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
H. Tang, Q. Hao, S. A. Rutherford, B. Low, and Z. J. Zhao Inactivation of Src Family Tyrosine Kinases by Reactive Oxygen Species in Vivo J. Biol. Chem., June 24, 2005; 280(25): 23918 - 23925. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Golas, J. Lucas, C. Etienne, J. Golas, C. Discafani, L. Sridharan, E. Boghaert, K. Arndt, F. Ye, D. H. Boschelli, et al. SKI-606, a Src/Abl Inhibitor with In vivo Activity in Colon Tumor Xenograft Models Cancer Res., June 15, 2005; 65(12): 5358 - 5364. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Rice, A. D. Dobrian, S. D. Schriver, and R. L. Prewitt Src Autophosphorylation is an Early Event in Pressure-Mediated Signaling Pathways in Isolated Resistance Arteries Hypertension, February 1, 2002; 39(2): 502 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. W.-L. Leung and N. Lassam The Kinase Activation Loop Is the Key to Mixed Lineage Kinase-3 Activation via Both Autophosphorylation and Hematopoetic Progenitor Kinase 1 Phosphorylation J. Biol. Chem., January 12, 2001; 276(3): 1961 - 1967. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |